The Patent Finder

X-RX, Inc.

Also on record
Records under this name other than patents X-RX, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to X-RX, Inc.

PatentTitleStatus Expires Confidence
US 9,951,056Substituted Nicotinamide Inhibitors of BTK and Their Preparation and Use in the Treatment of Cancer, Inflammation and Autoimmune Disease
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,394,256Benzhydrol-Pyrazole Derivatives Having Kinase Inhibitory Activity and Uses Thereof
Formerly held
Lapsed on the fee record
Ended Jul 19, 2024 · High confidence
Lapsed on the fee recordEnded Jul 19, 2024High confidence
US 9,394,296Tryptoline Derivatives Having Kinase Inhibitory Activity and Uses Thereof
Formerly held
Lapsed on the fee record
Ended Jul 19, 2024 · High confidence
Lapsed on the fee recordEnded Jul 19, 2024High confidence
US 10,233,182Substituted Spirocyclic Inhibitors of Autotaxin
Lapsed on the fee record
Ended Mar 19, 2023 · High confidence
Lapsed on the fee recordEnded Mar 19, 2023High confidence
US 10,011,601Substituted Spirocyclic Inhibitors of Autotaxin
Lapsed on the fee record
Ended Jul 3, 2022 · High confidence
Lapsed on the fee recordEnded Jul 3, 2022High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited